Home LiteratureArticle Details
PMID: 16085883 Published · ppublish English Journal Article

Adhesion of Vibrio cholerae to granular starches.

Applied and environmental microbiology ·Vol. 71 ·No. 8 ·2005-08-00 ·Pages 4850-5

Gancz H, Niderman-Meyer O, Broza M, Kashi Y, Shimoni E

Abstract

Cholera is a severe diarrheal disease caused by specific serogroups of Vibrio cholerae that are pathogenic to humans. Cholera can become epidemic and deadly without adequate medical care. Appropriate rehydration therapy can reduce the mortality rate from as much as 50% of the affected individuals to <1%. Thus, oral rehydration therapy (ORT) is an important measure in the treatment of this disease. To further reduce the symptoms associated with cholera, improvements in oral rehydration solution (ORS) by starch incorporation were suggested. Here, we report that V. cholerae adheres to starch granules incorporated in ORS. Adhesion of 98% of the cells was observed within 2 min when cornstarch granules were used. Other starches showed varied adhesion rates, indicating that starch source and composition play an important role in the interaction of V. cholerae and starch granules. Sugars metabolized by V. cholerae showed a repressive effect on the adhesion process. The possible mechanisms involved are discussed. Comparing V. cholerae adhesion with the adhesion of other pathogens suggests the involvement of starch degradation capabilities. This adhesion to granular starch can be used to improve ORT.

MeSH Terms
Animals Bacterial Adhesion Chironomidae/microbiology Fluid Therapy Green Fluorescent Proteins/genetics,metabolism Humans Ovum/microbiology Rehydration Solutions/chemistry Starch/chemistry,metabolism Vibrio cholerae O1/genetics,growth & development,isolation & purification,physiology
Chemicals
Rehydration Solutions Green Fluorescent Proteins Starch
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gancz Hanan
Department of Biotechnology and Food Engineering, The Technion, Haifa 32000, Israel.
Niderman-Meyer Orly
Broza Meir
Kashi Yechezkel
Shimoni Eyal
References (37)
37 references, click to expand
  1. Resistant starch as a prebiotic and synbiotic: state of the art.
    Proc Nutr Soc. 2003 Feb;62(1):171-6 PMID: 12749342
  2. Molecular characterization of Vibrio cholerae O139 bengal isolated from water and the aquatic plant Eichhornia crassipes in the River Ganga, Varanasi, India.
    Appl Environ Microbiol. 2003 Apr;69(4):2389-94 PMID: 12676727
  3. A PCR method based on 16S rRNA sequence for simultaneous detection of the genus Listeria and the species Listeria monocytogenes in food products.
    J Food Prot. 2003 Sep;66(9):1658-65 PMID: 14503721
  4. Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae.
    Dev Cell. 2003 Oct;5(4):647-56 PMID: 14536065
  5. Growth of Vibrio cholerae O1 in red tide waters off California.
    Appl Environ Microbiol. 2003 Nov;69(11):6923-31 PMID: 14602656
  6. Cholera.
    Lancet. 2004 Jan 17;363(9404):223-33 PMID: 14738797
  7. Rice-ORS versus glucose-ORS in management of severe cholera due to Vibrio cholerae O139 Bengal: a randomized, controlled clinical trial.
    J Health Popul Nutr. 2003 Dec;21(4):325-31 PMID: 15038587
  8. Control of diarrhoeal diseases: WHO's programme takes shape.
    WHO Chron. 1978 Oct;32(10):369-72 PMID: 716378
  9. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods.
    Appl Environ Microbiol. 1983 Jan;45(1):275-83 PMID: 6337551
  10. Electron microscopic study of Vibrio cholerae O1 adherence to the mucus coat and villus surface in the human small intestine.
    Infect Immun. 1988 Oct;56(10):2753-9 PMID: 3417355
  11. Oral rehydration of children with diarrhoea in Nigeria: a 12-year review of impact on morbidity and mortality from diarrhoeal diseases and diarrhoeal treatment practices.
    J Trop Pediatr. 1991 Mar;37(2):57-63 PMID: 2027165
  12. The treatment of cholera: clinical science at the bedside.
    J Infect Dis. 1992 Jul;166(1):2-14 PMID: 1607698
  13. Classification and measurement of nutritionally important starch fractions.
    Eur J Clin Nutr. 1992 Oct;46 Suppl 2:S33-50 PMID: 1330528
  14. The magnitude of the global problem of diarrhoeal disease: a ten-year update.
    Bull World Health Organ. 1992;70(6):705-14 PMID: 1486666
  15. A simple solution: curing diarrhea.
    J Diarrhoeal Dis Res. 1993 Mar;11(1):1-5 PMID: 8315248
  16. Diarrhoeal disease: current concepts and future challenges. The impact of oral rehydration and other therapies on the management of acute diarrhoea.
    Trans R Soc Trop Med Hyg. 1993 Dec;87 Suppl 3:35-8 PMID: 8108848
  17. Barriers to use of oral rehydration therapy.
    Pediatrics. 1994 May;93(5):708-11 PMID: 8165066
  18. The maltose regulon of Vibrio cholerae affects production and secretion of virulence factors.
    Infect Immun. 1994 Nov;62(11):4781-8 PMID: 7927755
  19. Cholera.
    Clin Microbiol Rev. 1995 Jan;8(1):48-86 PMID: 7704895
  20. A simple and rapid method for transformation of Vibrio species by electroporation.
    Methods Mol Biol. 1995;47:155-60 PMID: 7550730
  21. Measurement of resistant starch in vitro and in vivo.
    Br J Nutr. 1996 May;75(5):749-55 PMID: 8695601
  22. Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli.
    Mol Microbiol. 1997 Sep;25(6):1003-9 PMID: 9350858
  23. Enhancing clinical efficacy of oral rehydration therapy: is low osmolality the key?
    Gastroenterology. 1998 Jan;114(1):197-210 PMID: 9428233
  24. Oral rehydration solution in the year 2000: pathophysiology, efficacy and effectiveness.
    Baillieres Clin Gastroenterol. 1997 Sep;11(3):509-27 PMID: 9448913
  25. Purification of a mannose/glucose-specific hemagglutinin/lectin from a Vibrio cholerae O1 strain.
    FEMS Immunol Med Microbiol. 1999 Mar;23(3):221-7 PMID: 10219594
  26. A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor.
    J Bacteriol. 1999 Jun;181(11):3606-9 PMID: 10348878
  27. How Vibrio cholerae survive during starvation.
    FEMS Microbiol Lett. 1999 Nov 15;180(2):123-31 PMID: 10556702
  28. Amylase-resistant starch plus oral rehydration solution for cholera.
    N Engl J Med. 2000 Feb 3;342(5):308-13 PMID: 10655529
  29. Rice-based oral rehydration solution for treating diarrhoea.
    Cochrane Database Syst Rev. 2000;(2):CD001264 PMID: 10796624
  30. Bangladeshi rural mothers prepare safer rice oral rehydration solution.
    Acta Paediatr. 2000 Jul;89(7):791-4 PMID: 10943959
  31. Improved gfp and inaZ broad-host-range promoter-probe vectors.
    Mol Plant Microbe Interact. 2000 Nov;13(11):1243-50 PMID: 11059491
  32. Characterization of the groESL operon in Listeria monocytogenes: utilization of two reporter systems (gfp and hly) for evaluating in vivo expression.
    Infect Immun. 2001 Jun;69(6):3924-32 PMID: 11349060
  33. The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton.
    Appl Environ Microbiol. 2001 Jul;67(7):3220-5 PMID: 11425745
  34. Efficacy of a packaged rice oral rehydration solution among children with cholera and cholera-like illness.
    Acta Paediatr. 2001 May;90(5):505-10 PMID: 11430708
  35. Pathogen reservoirs. Chironomid egg masses and Vibrio cholerae.
    Nature. 2001 Jul 5;412(6842):40 PMID: 11452294
  36. Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers.
    FEBS Lett. 2003 Feb 27;537(1-3):53-7 PMID: 12606030
  37. Vibrio cholerae hemagglutinin/protease degrades chironomid egg masses.
    Appl Environ Microbiol. 2003 Jul;69(7):4200-4 PMID: 12839800
Article Info
Journal
Applied and environmental microbiology
Abbr.
Appl Environ Microbiol
ISSN
0099-2240
Published
2005-08-00
Pages
4850-5
Language
English
Region
United States
NLM ID
7605801
PMCID
PMC1183348
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com